Urinary phthalate/DINCH metabolites associations with kisspeptin and reproductive hormones in teenagers: A cross-sectional study from the HBM4EU aligned studies.

DINCH Effect biomarkers HBM4EU Kisspeptin Phthalates Reproductive hormones

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
15 Apr 2024
Historique:
received: 22 12 2023
revised: 09 04 2024
accepted: 10 04 2024
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 17 4 2024
Statut: aheadofprint

Résumé

Exposure to phthalate/DINCH metabolites can induce human reproductive toxicity, however, their endocrine-disrupting mechanisms are not fully elucidated. To investigate the association between concentrations of phthalate/DINCH metabolites, serum kisspeptin, and reproductive hormones among European teenagers from three of the HBM4EU Aligned Studies. In 733 Belgian (FLEHS IV study), Slovak (PCB cohort follow-up), and Spanish (BEA study) teenagers, ten phthalate and two DINCH metabolites were measured in urine by high-performance liquid chromatography-tandem mass spectrometry. Serum kisspeptin (kiss54) protein, follicle-stimulating hormone (FSH), total testosterone (TT), estradiol (E2), and sex hormone-binding globulin (SHBG) levels were measured by immunosorbent assays. Free Androgen Index (FAI) was calculated as a proxy of free testosterone. Adjusted sex-stratified linear regression models for individual studies, mixed effect models (LME) accounting for random effects for pooled studies, and g-computation and Bayesian kernel machine regression (BKMR) models for the phthalate/DINCH mixture were performed. The LME suggested that each IQR increase in ln-transformed levels of several phthalates was associated with lower kisspeptin [MnBP: %change (95%CI): -2.8 (-4.2;-0.4); MEHP: -1.4 (-3.4,0.2)] and higher FSH [∑DINP: 11.8 (-0.6;25.1)] levels in females from pooled studies. G-computation showed that the phthalates/DINCH mixture was associated with lower kisspeptin [-4.28 (-8.07;-0.34)] and higher FSH [22.13 (0.5;48.4)] also in females; BKMR showed similar although non-significant pattern. In males, higher phthalates metabolites [MEHP: -12.22 (-21.09;-1.18); oxo-MEHP: -12.73 (-22.34;-1.93)] were associated with lower TT and FAI, although higher DINCH [OH-MINCH: 16.31 (6.23;27.35), cx-MINCH: 16.80 (7.03;27.46), ∑DINCH: 17.37 (7.26;29.74)] were associated with higher TT levels. No mixture associations were found in males. We observed sex-specific associations between urinary concentrations of phthalate/DINCH metabolites and the panel of selected effect biomarkers (kisspeptin and reproductive hormones). This suggests that exposure to phthalates would be associated with changes in kisspeptin levels, which would affect the HPG axis and thus influence reproductive health. However, further research is needed, particularly for phthalate replacements such as DINCH.

Sections du résumé

BACKGROUND BACKGROUND
Exposure to phthalate/DINCH metabolites can induce human reproductive toxicity, however, their endocrine-disrupting mechanisms are not fully elucidated.
OBJECTIVE OBJECTIVE
To investigate the association between concentrations of phthalate/DINCH metabolites, serum kisspeptin, and reproductive hormones among European teenagers from three of the HBM4EU Aligned Studies.
METHODS METHODS
In 733 Belgian (FLEHS IV study), Slovak (PCB cohort follow-up), and Spanish (BEA study) teenagers, ten phthalate and two DINCH metabolites were measured in urine by high-performance liquid chromatography-tandem mass spectrometry. Serum kisspeptin (kiss54) protein, follicle-stimulating hormone (FSH), total testosterone (TT), estradiol (E2), and sex hormone-binding globulin (SHBG) levels were measured by immunosorbent assays. Free Androgen Index (FAI) was calculated as a proxy of free testosterone. Adjusted sex-stratified linear regression models for individual studies, mixed effect models (LME) accounting for random effects for pooled studies, and g-computation and Bayesian kernel machine regression (BKMR) models for the phthalate/DINCH mixture were performed.
RESULTS RESULTS
The LME suggested that each IQR increase in ln-transformed levels of several phthalates was associated with lower kisspeptin [MnBP: %change (95%CI): -2.8 (-4.2;-0.4); MEHP: -1.4 (-3.4,0.2)] and higher FSH [∑DINP: 11.8 (-0.6;25.1)] levels in females from pooled studies. G-computation showed that the phthalates/DINCH mixture was associated with lower kisspeptin [-4.28 (-8.07;-0.34)] and higher FSH [22.13 (0.5;48.4)] also in females; BKMR showed similar although non-significant pattern. In males, higher phthalates metabolites [MEHP: -12.22 (-21.09;-1.18); oxo-MEHP: -12.73 (-22.34;-1.93)] were associated with lower TT and FAI, although higher DINCH [OH-MINCH: 16.31 (6.23;27.35), cx-MINCH: 16.80 (7.03;27.46), ∑DINCH: 17.37 (7.26;29.74)] were associated with higher TT levels. No mixture associations were found in males.
CONCLUSION CONCLUSIONS
We observed sex-specific associations between urinary concentrations of phthalate/DINCH metabolites and the panel of selected effect biomarkers (kisspeptin and reproductive hormones). This suggests that exposure to phthalates would be associated with changes in kisspeptin levels, which would affect the HPG axis and thus influence reproductive health. However, further research is needed, particularly for phthalate replacements such as DINCH.

Identifiants

pubmed: 38631641
pii: S0048-9697(24)02572-5
doi: 10.1016/j.scitotenv.2024.172426
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

172426

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Auteurs

Andrea Rodríguez-Carrillo (A)

VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; Toxicological Centre, University of Antwerp, Universiteitsplein, 1, 2610 Wilrijk, Belgium.

Sylvie Remy (S)

VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.

Gudrun Koppen (G)

VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.

Natasha Wauters (N)

VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.

Vicente Mustieles (V)

Biomedical Research Center & School of Medicine, University of Granada, 18016 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Spain.

Anteneh Desalegn (A)

Division of Climate and Environmental Health, Norwegian Institute of Public Health, Norway.

Nina Iszatt (N)

Division of Climate and Environmental Health, Norwegian Institute of Public Health, Norway.

Elly den Hond (E)

Provincial Institute for Hygiene, Antwerp, Belgium.

Veerle J Verheyen (VJ)

VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.

Lucia Fábelová (L)

Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, Bratislava, Slovakia.

Lubica Palkovicova Murinova (LP)

Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, Bratislava, Slovakia.

Susana Pedraza-Díaz (S)

National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain.

Marta Esteban (M)

National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain.

Rafael M Poyatos (RM)

Hospital Universitario Clínico San Cecilio, Granada, Spain.

Eva Govarts (E)

VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.

Alexander L N van Nuijs (ALN)

Toxicological Centre, University of Antwerp, Universiteitsplein, 1, 2610 Wilrijk, Belgium.

Adrian Covaci (A)

Toxicological Centre, University of Antwerp, Universiteitsplein, 1, 2610 Wilrijk, Belgium.

Greet Schoeters (G)

Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016 Granada, Spain.

Nicolás Olea (N)

Biomedical Research Center & School of Medicine, University of Granada, 18016 Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Spain.

Mariana F Fernández (MF)

Biomedical Research Center & School of Medicine, University of Granada, 18016 Granada, Spain; Department of Radiology and Physical Medicine, School of Medicine, University of Granada, 18016 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Spain. Electronic address: marieta@ugr.es.

Classifications MeSH